Name: Orchestra BioMed Holdings, Inc. (OBIO) Financial Statements
Creator: FinSpry

Orchestra BioMed Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Orchestra BioMed Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	2.64	2.76	3.53	-0.78	5.70
Cost of Revenue	0.20	0.19	0.21	0.20	0.15
Gross Profit	2.43	2.57	3.32	-0.98	5.56
Operating Expenses
Research & Development	42.80	33.82	21.95	12.89	13.48
Selling, General & Administrative	23.93	20.26	14.03	7.93	10.83
Operating Expenses	66.74	54.08	35.98	20.82	24.31
Operating Income	-64.30	-51.51	-32.66	-21.80	-18.75
Other Income/Expense
Interest Income	3.36	5.25	0.05	0.00	0.33
Interest Expense	-0.30	-1.40	0.00	-0.93	0.00
Other Income/Expense	-0.08	-0.29	-1.00	0.70	-0.18
Income
Income Before Tax	-61.02	-49.12	-33.61	-23.01	-21.36
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-61.02	-49.12	-33.61	-23.01	-21.36
Net Income - Continuous Operations	-61.02	-49.12	-33.61	-23.01	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-63.99	-51.22	-32.44	-21.62	-18.62
EBIT	-64.30	-51.51	-32.66	-21.80	-18.75
Depreciation & Amortization	0.31	0.29	0.22	0.18	0.14
Earnings Per Share
Basic EPS	-2.00	-1.00	-1.00	-11.00	-11.00
Diluted EPS	-2.00	-1.00	-1.00	-11.00	-11.00
Basic Shares Outstanding	36.82	33.23	31.61	2.11	2.01
Diluted Shares Outstanding	36.82	33.23	31.61	2.11	2.01